Sign in

CIK 0001553643

  • Non-accelerated filer
  • Smaller reporting company

RELMADA THERAPEUTICS, INC.

Sign in to watch
Ticker
RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
455401931
Phone
+1 646-876-3459
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Former names
CAMP NINE, INC.
Open-market buys, last 90 days
$1,671,990
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Shenouda Maged +$844K Chief Financial Officer 1 filing
  2. TRAVERSA SERGIO +$828K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2015-12-14 TRAVERSA SERGIO Chief Executive Officer Purchase +30 $2.97 $89 320,352
2015-12-14 Shenouda Maged Director Purchase +2,000 $2.89 $6K 2,000
2015-12-14 CASAMENTO CHARLES J Director Purchase +1,700 $2.98 $5K 1,700
2015-12-14 CASAMENTO CHARLES J Director Purchase +1,300 $2.97 $4K 3,000
2015-12-14 CASAMENTO CHARLES J Director Purchase +300 $2.90 $870 3,300
2015-12-14 CASAMENTO CHARLES J Director Purchase +500 $2.95 $1K 3,800
2015-12-14 CASAMENTO CHARLES J Director Purchase +400 $2.98 $1K 4,200
2015-02-23 TRAVERSA SERGIO Chief Executive Officer Grant or award · Options to purchase common stock +225,000 $2.70 $608K 872,745
2015-02-23 Salinas Eliseo Oreste President and CSO Grant or award · Options to purchase common stock +225,000 $2.70 $608K 250,944
2015-02-23 BECK DOUGLAS Chief Financial Officer Grant or award · Options to purchase common stock +25,000 $2.70 $68K 104,437

Page 19 of 19 · 370 trades